[go: up one dir, main page]

WO2000020584A3 - Gene human 36p1a6 exprime dans le cancer de la prostate, de la vessie, du pancreas et du colon - Google Patents

Gene human 36p1a6 exprime dans le cancer de la prostate, de la vessie, du pancreas et du colon Download PDF

Info

Publication number
WO2000020584A3
WO2000020584A3 PCT/US1999/022576 US9922576W WO0020584A3 WO 2000020584 A3 WO2000020584 A3 WO 2000020584A3 US 9922576 W US9922576 W US 9922576W WO 0020584 A3 WO0020584 A3 WO 0020584A3
Authority
WO
WIPO (PCT)
Prior art keywords
pancreas
cancers
colon
prostate
bladder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/022576
Other languages
English (en)
Other versions
WO2000020584A2 (fr
WO2000020584A9 (fr
Inventor
Daniel E Afar
Rene S Hubert
Stephen Chappell Mitchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agensys Inc
Original Assignee
Urogenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urogenesys Inc filed Critical Urogenesys Inc
Priority to IL14231099A priority Critical patent/IL142310A0/xx
Priority to AU10975/00A priority patent/AU1097500A/en
Priority to CA002344552A priority patent/CA2344552A1/fr
Priority to EP99954686A priority patent/EP1117794A2/fr
Publication of WO2000020584A2 publication Critical patent/WO2000020584A2/fr
Publication of WO2000020584A3 publication Critical patent/WO2000020584A3/fr
Publication of WO2000020584A9 publication Critical patent/WO2000020584A9/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne un nouveau gène humain exprimé dans le cancer de la prostate, de la vessie, du pancréas, du colon, du col et des ovaires. L'invention concerne en outre de l'ADNc entier qui code un facteur de transcription présumée, avec un degré d'homologie élevé par rapport au gène EHF murin et à la protéine ESX humaine.
PCT/US1999/022576 1998-10-02 1999-10-02 Gene human 36p1a6 exprime dans le cancer de la prostate, de la vessie, du pancreas et du colon Ceased WO2000020584A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IL14231099A IL142310A0 (en) 1998-10-02 1999-10-02 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
AU10975/00A AU1097500A (en) 1998-10-02 1999-10-02 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
CA002344552A CA2344552A1 (fr) 1998-10-02 1999-10-02 Gene human 36p1a6 exprime dans le cancer de la prostate, de la vessie, du pancreas et du colon
EP99954686A EP1117794A2 (fr) 1998-10-02 1999-10-02 Gene human 36p1a6 exprime dans le cancer de la prostate, de la vessie, du pancreas et du colon

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10274498P 1998-10-02 1998-10-02
US60/102,744 1998-10-02
US14644799P 1999-07-29 1999-07-29
US60/146,447 1999-07-29

Publications (3)

Publication Number Publication Date
WO2000020584A2 WO2000020584A2 (fr) 2000-04-13
WO2000020584A3 true WO2000020584A3 (fr) 2000-07-06
WO2000020584A9 WO2000020584A9 (fr) 2000-08-31

Family

ID=26799687

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/022576 Ceased WO2000020584A2 (fr) 1998-10-02 1999-10-02 Gene human 36p1a6 exprime dans le cancer de la prostate, de la vessie, du pancreas et du colon

Country Status (5)

Country Link
EP (1) EP1117794A2 (fr)
AU (1) AU1097500A (fr)
CA (1) CA2344552A1 (fr)
IL (1) IL142310A0 (fr)
WO (1) WO2000020584A2 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037093A2 (fr) * 1997-02-25 1998-08-27 Corixa Corporation Composes permettant l'immunotherapie du cancer de la prostate et procedes concernant leur utilisation
WO1998037418A2 (fr) * 1997-02-25 1998-08-27 Corixa Corporation Composes servant au diagnostic immunologique de cancer de la prostate et leurs procedes d'utilisation
WO1999037809A1 (fr) * 1998-01-21 1999-07-29 Axys Pharmaceuticals, Inc. Genes associes a l'asthme
WO1999062942A2 (fr) * 1998-06-01 1999-12-09 Urogenesys, Inc. Nouvel antigene tumoral utile dans le diagnostic et la therapie propres au cancer de la prostate et du colon
WO2000004149A2 (fr) * 1998-07-14 2000-01-27 Corixa Corporation Compositions et methodes de therapie et de diagnostic du cancer de la prostate

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037093A2 (fr) * 1997-02-25 1998-08-27 Corixa Corporation Composes permettant l'immunotherapie du cancer de la prostate et procedes concernant leur utilisation
WO1998037418A2 (fr) * 1997-02-25 1998-08-27 Corixa Corporation Composes servant au diagnostic immunologique de cancer de la prostate et leurs procedes d'utilisation
WO1999037809A1 (fr) * 1998-01-21 1999-07-29 Axys Pharmaceuticals, Inc. Genes associes a l'asthme
WO1999062942A2 (fr) * 1998-06-01 1999-12-09 Urogenesys, Inc. Nouvel antigene tumoral utile dans le diagnostic et la therapie propres au cancer de la prostate et du colon
WO2000004149A2 (fr) * 1998-07-14 2000-01-27 Corixa Corporation Compositions et methodes de therapie et de diagnostic du cancer de la prostate

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BOCHERT M A ET AL: "MOLECULAR CLONING AND EXPRESSION OF EHF, A NEW MEMBER OF THE ETS TRANSCRIPTION FACTOR/ONCOPROTEIN GENE FAMILY", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,US,ACADEMIC PRESS INC. ORLANDO, FL, vol. 246, no. 1, 1998, pages 176 - 181, XP000867344, ISSN: 0006-291X *
CHANG C -H ET AL: "ESX: A STRUCTURALLY UNIQUE ETS OVEREXPRESSED EARLY DURING HUMAN BREAST TUMORIGENESIS", ONCOGENE,GB,BASINGSTOKE, HANTS, vol. 14, no. 13, 1997, pages 1617 - 1622, XP000870110, ISSN: 0950-9232 *
L.A. KLEINBAUM ET AL.: "Human chromosomal localization, tissue/tumor expression, and regulatory function of the ets family gene EHF.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,US,ACADEMIC PRESS INC. ORLANDO, FL, vol. 264, 1999, pages 119 - 126, XP002136361 *

Also Published As

Publication number Publication date
WO2000020584A2 (fr) 2000-04-13
IL142310A0 (en) 2002-03-10
WO2000020584A9 (fr) 2000-08-31
EP1117794A2 (fr) 2001-07-25
CA2344552A1 (fr) 2000-04-13
AU1097500A (en) 2000-04-26

Similar Documents

Publication Publication Date Title
CA98438S (en) Spout
CA97230S (en) Escutcheon
DE59711046D1 (de) Herstellung von pulverförmigen, kaltwasserdispergierbaren Carotinoid-Zubereitungen und die Verwendung der neuen Carotinoid-Zubereitnungen
CA97229S (en) Escutcheon
AU3361895A (en) Digital radio with vocoding encrypting codec
CA96618S (en) Beer cask with tap
CA2256645A1 (fr) .alpha.-2,3-sialyltransferases recombinantes et leurs utilisations
CA97202S (en) Airplane
CA99702S (en) Airplane
WO2000020584A3 (fr) Gene human 36p1a6 exprime dans le cancer de la prostate, de la vessie, du pancreas et du colon
WO2002029154A3 (fr) Drap de bain mince et doux, a toucher volumineux
CA97193S (en) Faucet body
AU2001292958A1 (en) Biomarkers of transitional cell carcinoma of the bladder
AU7876100A (en) Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof
CA98135S (en) Colander
WO2000012709A3 (fr) Phelix: proteine specifique des testicules exprimee dans le cancer
WO2001068868A3 (fr) Sous-unite alpha(iii) de prolyl-4-hydroxylase
CA97879S (en) Faucet
WO1999029720A3 (fr) Proteine 1 mammalienne a helice alpha
AU3848397A (en) Water outflow for a sanitary fitting
IT1284689B1 (it) Serratura, con dispositivo di sicurezza per abilitare l'introduzione della chiave nella serrtura.
CA97180S (en) Faucet
IT235640Y1 (it) Bidet con rubinetto disposto frontalmente all'utilizzatore.
WO1999051730A3 (fr) Gene et proteine de mammifere de type tolloide
Grignon et al. Pathologic Stage T1 Carcinoma of the Bladder: Clinical Implications and Prognostic Significance.

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 10975

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A2

Designated state(s): AT AT AU BR CA CH CN DE DE DK DK ES FI FI GB IL JP KR MX NO NZ RU SE SG

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AT AT AU BR CA CH CN DE DE DK DK ES FI FI GB IL JP KR MX NO NZ RU SE SG

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: C2

Designated state(s): AT AT AU BR CA CH CN DE DE DK DK ES FI FI GB IL JP KR MX NO NZ RU SE SG

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 1/9-9/9, DRAWINGS, REPLACED BY NEW PAGES 1/10-10/10; DUE TO LATE TRANSMITTAL BY THE RECEIVINGOFFICE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2344552

Country of ref document: CA

Ref country code: CA

Ref document number: 2344552

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 10975/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1999954686

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999954686

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999954686

Country of ref document: EP